We are monitoring the impact of COVID-19 on Europe Companion Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 590
Share on
Share on

Europe Companion Diagnostics Market Research Report – Segmented By Indication, By Technology & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2020 to 2025)

Pulished: February, 2020
ID: 590
Pages: 145

Europe Companion Diagnostics Market Size & Growth (2020 to 2025)

As per the report, the size of the Companion Diagnostics Market in Europe was worth USD 0.91 million in 2020 and estimated to be growing at a CAGR of 20.66%, to reach USD 2.32 million by 2025.

The continued expansion of companion diagnostics will also have a global module as markets in Europe will develop in a similar but not identical pattern as the US.

Companion diagnostics are an essential part of modified medicine and will likely continue to rapidly rise in number and application to disease areas. Companion diagnostics and targeted therapeutics are the pillars of personalized medicine. Aspects of genetic testing are used for testing possible abnormalities and modifying the treatment so as to make it as personalized as the disease itself.

A major driver for the growth of the market will continue to be the economic reasons for drug developers to pair their products with diagnostics. Restricted regulatory barriers for drug and diagnostic combination products, which the current IVD directive classifies under the low-risk category, are accelerating market access. One of the greatest challenges to future growth in companion diagnostics is supporting the inducements of all stakeholders.

This research report segmented and sub-segmented into the following categories:

  • By Indication: Oncology, Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases
  • By Technology: Immunohistochemistry, Molecular Diagnostics
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Regionally, with the increasing initiatives from government Germany is growing at the highest rate in this region.

Promising companies operating in the Europe Companion Diagnostics Market profiled in this report are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc., Biogenex Laboratories Inc., Ventana Medical Systems Inc. and Thermo Fisher Scientific Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 U.K 

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Companion Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  2. Europe Companion Diagnostics Market By Indication, From 2020 to 2025 (USD Billion)
  3. Europe Oncology Market By Region, From 2020 to 2025 (USD Billion)
  4. Europe Inflammation and Autoimmune Diseases Market By Region, From 2020 to 2025 (USD Billion)
  5. Europe Cardiovascular Diseases Market By Region, From 2020 to 2025 (USD Billion)
  6. Europe Central Nervous System Disorders Market By Region, From 2020 to 2025 (USD Billion)
  7. Europe Virology Diseases Market By Region, From 2020 to 2025 (USD Billion)
  8. Europe Companion Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  9. Europe Immuno Histochemistry Market By Region, From 2020 to 2025 (USD Billion)
  10. Europe Molecular Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  11. Europe Oncology Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  12. Europe Colorectal Cancer Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  13. Europe Breast Cancer Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  14. Europe Lung Cancer Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  15. Europe Gastric Cancer Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  16. Europe Melanoma Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  17. Europe Molecular Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  18. Europe In-Situ Hybridization Market By Region, From 2020 to 2025 (USD Billion)
  19. Europe Real Time PCR Market By Region, From 2020 to 2025 (USD Billion)
  20. Europe Gene Sequencing Market By Region, From 2020 to 2025 (USD Billion)
  21. U.K Companion Diagnostics Market By Indication, From 2020 to 2025 (USD Billion)
  22. U.K Companion Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  23. U.K Oncology Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  24. U.K Molecular Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  25. Spain Companion Diagnostics Market By Indication, From 2020 to 2025 (USD Billion)
  26. Spain Companion Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  27. Spain Oncology Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  28. Spain Molecular Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  29. Germany Companion Diagnostics Market By Indication, From 2020 to 2025 (USD Billion)
  30. Germany Companion Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  31. Germany Oncology Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  32. Germany Molecular Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  33. Italy Companion Diagnostics Market By Indication, From 2020 to 2025 (USD Billion)
  34. Italy Companion Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  35. Italy Oncology Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  36. Italy Molecular Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  37. France Companion Diagnostics Market By Indication, From 2020 to 2025 (USD Billion)
  38. France Companion Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  39. France Oncology Diagnostics Market By Type, From 2020 to 2025 (USD Billion)
  40. France Molecular Diagnostics Market By Type, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample